Loading…

Non-specific in vivo inhibition of CK1 by the pyridinyl imidazole p38 inhibitors SB 203580 and SB 202190

Small-molecule inhibitors of protein kinases have contributed immensely to our understanding of biological signaling pathways and have been exploited therapeutically for the treatment of cancers and other disease states. The pyridinyl imidazole compounds SB 203580 and SB 202190 were identified as AT...

Full description

Saved in:
Bibliographic Details
Published in:BMB reports 2009-03, Vol.42 (3), p.142-147
Main Authors: Shanware, Naval P. (The University of Wisconsin-Madison Medical School, WI, Madison, USA), Williams, Leah M. (The University of Wisconsin-Madison Medical School, WI, Madison, USA), Bowler, Michael J. (The University of Wisconsin-Madison Medical School, WI, Madison, USA), Tibbetts, Randal S. (The University of Wisconsin-Madison Medical School, WI, Madison, USA), E-mail: rstibbetts@wisc.edu
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c545t-662e1cf0abe5aceeee60e1c5800a8d47d83828cf8342cb6a058d678dc70e7a883
cites cdi_FETCH-LOGICAL-c545t-662e1cf0abe5aceeee60e1c5800a8d47d83828cf8342cb6a058d678dc70e7a883
container_end_page 147
container_issue 3
container_start_page 142
container_title BMB reports
container_volume 42
creator Shanware, Naval P. (The University of Wisconsin-Madison Medical School, WI, Madison, USA)
Williams, Leah M. (The University of Wisconsin-Madison Medical School, WI, Madison, USA)
Bowler, Michael J. (The University of Wisconsin-Madison Medical School, WI, Madison, USA)
Tibbetts, Randal S. (The University of Wisconsin-Madison Medical School, WI, Madison, USA), E-mail: rstibbetts@wisc.edu
description Small-molecule inhibitors of protein kinases have contributed immensely to our understanding of biological signaling pathways and have been exploited therapeutically for the treatment of cancers and other disease states. The pyridinyl imidazole compounds SB 203580 and SB 202190 were identified as ATP competitive antagonists of the p38 stress-activated protein kinases and have been widely used to elucidate p38-dependent cellular processes. Here, we identify S8 203580 and SB 202190 as potent inhibitors of stress-induced CREB phosphorylation on Serine 111 (Ser-111) in intact cells. Unexpectedly, we found that the inhibitory activity of SB 203580 and SB 202190 on CREB phosphorylation was independent of p38, but instead correlated with inhibition of casein kinase 1 (CK1) in vitro. The inhibition of CK1-mediated CREB phosphorylation by concentrations of pyridinyl imidazoles commonly employed to suppress p38, suggests that in some cases conclusions of p38-dependence derived solely from the use of these inhibitors may be invalid.
doi_str_mv 10.5483/bmbrep.2009.42.3.142
format article
fullrecord <record><control><sourceid>pubmed_cross</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4412876</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>19336000</sourcerecordid><originalsourceid>FETCH-LOGICAL-c545t-662e1cf0abe5aceeee60e1c5800a8d47d83828cf8342cb6a058d678dc70e7a883</originalsourceid><addsrcrecordid>eNpVkNtKAzEQhoMoWqtvoJIX6Do5bJK9EWzxhFWhKngXstmsjbSbJVsL9elNqcfcTObP_N-EH6EjAlnOFTst52V0bUYBiozTjGWE0y3UI4UUAyHhZfv7Lgqxh_a77g1AECrpLtojBWMCAHpoeh-aQdc662tvsW_w0i9DqlNf-oUPDQ41Ht0SXK7wYupwu4q-8s1qhv3cV-YjzJLG1LchxA4_DjEFlivApqk2HSUFHKCd2sw6d_hV--j58uJpdD0YP1zdjM7HA5vzfJF-Sx2xNZjS5ca6dAQkIeHAqIrLSjFFla0V49SWwkCuKiFVZSU4aZRifXS24bbv5dxV1jWLaGa6jX5u4koH4_X_l8ZP9WtYas4JVVIkAN8AbAxdF1394yWg18nr4d1w4lq9Tl5zqplOySfbyd-9v6avqNPA8WagNkGb1-g7fTtZMwA4kzn7BNYUiL4</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Non-specific in vivo inhibition of CK1 by the pyridinyl imidazole p38 inhibitors SB 203580 and SB 202190</title><source>Free Full-Text Journals in Chemistry</source><creator>Shanware, Naval P. (The University of Wisconsin-Madison Medical School, WI, Madison, USA) ; Williams, Leah M. (The University of Wisconsin-Madison Medical School, WI, Madison, USA) ; Bowler, Michael J. (The University of Wisconsin-Madison Medical School, WI, Madison, USA) ; Tibbetts, Randal S. (The University of Wisconsin-Madison Medical School, WI, Madison, USA), E-mail: rstibbetts@wisc.edu</creator><creatorcontrib>Shanware, Naval P. (The University of Wisconsin-Madison Medical School, WI, Madison, USA) ; Williams, Leah M. (The University of Wisconsin-Madison Medical School, WI, Madison, USA) ; Bowler, Michael J. (The University of Wisconsin-Madison Medical School, WI, Madison, USA) ; Tibbetts, Randal S. (The University of Wisconsin-Madison Medical School, WI, Madison, USA), E-mail: rstibbetts@wisc.edu</creatorcontrib><description>Small-molecule inhibitors of protein kinases have contributed immensely to our understanding of biological signaling pathways and have been exploited therapeutically for the treatment of cancers and other disease states. The pyridinyl imidazole compounds SB 203580 and SB 202190 were identified as ATP competitive antagonists of the p38 stress-activated protein kinases and have been widely used to elucidate p38-dependent cellular processes. Here, we identify S8 203580 and SB 202190 as potent inhibitors of stress-induced CREB phosphorylation on Serine 111 (Ser-111) in intact cells. Unexpectedly, we found that the inhibitory activity of SB 203580 and SB 202190 on CREB phosphorylation was independent of p38, but instead correlated with inhibition of casein kinase 1 (CK1) in vitro. The inhibition of CK1-mediated CREB phosphorylation by concentrations of pyridinyl imidazoles commonly employed to suppress p38, suggests that in some cases conclusions of p38-dependence derived solely from the use of these inhibitors may be invalid.</description><identifier>ISSN: 1976-6696</identifier><identifier>EISSN: 1976-670X</identifier><identifier>DOI: 10.5483/bmbrep.2009.42.3.142</identifier><identifier>PMID: 19336000</identifier><language>eng</language><publisher>Korea (South)</publisher><subject>Casein kinase ; Casein Kinase I - antagonists &amp; inhibitors ; Cell Line ; CICLOHEXIMIDA ; CK1 ; CK2 ; CREB ; Cyclic AMP Response Element-Binding Protein - metabolism ; CYCLOHEXIMIDE ; Humans ; Imidazoles - pharmacology ; Non-specific ; p38 ; p38 Mitogen-Activated Protein Kinases - antagonists &amp; inhibitors ; Phosphorylation - drug effects ; Phosphoserine - metabolism ; Protein Biosynthesis - drug effects ; Protein Kinase Inhibitors - pharmacology ; Pyridines - pharmacology ; SB202190 ; SB203580 ; Stress, Physiological - drug effects ; Stress-activated protein kinase ; Substrate Specificity - drug effects ; Suppression, Genetic - drug effects</subject><ispartof>BMB reports, 2009-03, Vol.42 (3), p.142-147</ispartof><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c545t-662e1cf0abe5aceeee60e1c5800a8d47d83828cf8342cb6a058d678dc70e7a883</citedby><cites>FETCH-LOGICAL-c545t-662e1cf0abe5aceeee60e1c5800a8d47d83828cf8342cb6a058d678dc70e7a883</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,776,780,881,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/19336000$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Shanware, Naval P. (The University of Wisconsin-Madison Medical School, WI, Madison, USA)</creatorcontrib><creatorcontrib>Williams, Leah M. (The University of Wisconsin-Madison Medical School, WI, Madison, USA)</creatorcontrib><creatorcontrib>Bowler, Michael J. (The University of Wisconsin-Madison Medical School, WI, Madison, USA)</creatorcontrib><creatorcontrib>Tibbetts, Randal S. (The University of Wisconsin-Madison Medical School, WI, Madison, USA), E-mail: rstibbetts@wisc.edu</creatorcontrib><title>Non-specific in vivo inhibition of CK1 by the pyridinyl imidazole p38 inhibitors SB 203580 and SB 202190</title><title>BMB reports</title><addtitle>BMB Rep</addtitle><description>Small-molecule inhibitors of protein kinases have contributed immensely to our understanding of biological signaling pathways and have been exploited therapeutically for the treatment of cancers and other disease states. The pyridinyl imidazole compounds SB 203580 and SB 202190 were identified as ATP competitive antagonists of the p38 stress-activated protein kinases and have been widely used to elucidate p38-dependent cellular processes. Here, we identify S8 203580 and SB 202190 as potent inhibitors of stress-induced CREB phosphorylation on Serine 111 (Ser-111) in intact cells. Unexpectedly, we found that the inhibitory activity of SB 203580 and SB 202190 on CREB phosphorylation was independent of p38, but instead correlated with inhibition of casein kinase 1 (CK1) in vitro. The inhibition of CK1-mediated CREB phosphorylation by concentrations of pyridinyl imidazoles commonly employed to suppress p38, suggests that in some cases conclusions of p38-dependence derived solely from the use of these inhibitors may be invalid.</description><subject>Casein kinase</subject><subject>Casein Kinase I - antagonists &amp; inhibitors</subject><subject>Cell Line</subject><subject>CICLOHEXIMIDA</subject><subject>CK1</subject><subject>CK2</subject><subject>CREB</subject><subject>Cyclic AMP Response Element-Binding Protein - metabolism</subject><subject>CYCLOHEXIMIDE</subject><subject>Humans</subject><subject>Imidazoles - pharmacology</subject><subject>Non-specific</subject><subject>p38</subject><subject>p38 Mitogen-Activated Protein Kinases - antagonists &amp; inhibitors</subject><subject>Phosphorylation - drug effects</subject><subject>Phosphoserine - metabolism</subject><subject>Protein Biosynthesis - drug effects</subject><subject>Protein Kinase Inhibitors - pharmacology</subject><subject>Pyridines - pharmacology</subject><subject>SB202190</subject><subject>SB203580</subject><subject>Stress, Physiological - drug effects</subject><subject>Stress-activated protein kinase</subject><subject>Substrate Specificity - drug effects</subject><subject>Suppression, Genetic - drug effects</subject><issn>1976-6696</issn><issn>1976-670X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2009</creationdate><recordtype>article</recordtype><recordid>eNpVkNtKAzEQhoMoWqtvoJIX6Do5bJK9EWzxhFWhKngXstmsjbSbJVsL9elNqcfcTObP_N-EH6EjAlnOFTst52V0bUYBiozTjGWE0y3UI4UUAyHhZfv7Lgqxh_a77g1AECrpLtojBWMCAHpoeh-aQdc662tvsW_w0i9DqlNf-oUPDQ41Ht0SXK7wYupwu4q-8s1qhv3cV-YjzJLG1LchxA4_DjEFlivApqk2HSUFHKCd2sw6d_hV--j58uJpdD0YP1zdjM7HA5vzfJF-Sx2xNZjS5ca6dAQkIeHAqIrLSjFFla0V49SWwkCuKiFVZSU4aZRifXS24bbv5dxV1jWLaGa6jX5u4koH4_X_l8ZP9WtYas4JVVIkAN8AbAxdF1394yWg18nr4d1w4lq9Tl5zqplOySfbyd-9v6avqNPA8WagNkGb1-g7fTtZMwA4kzn7BNYUiL4</recordid><startdate>20090331</startdate><enddate>20090331</enddate><creator>Shanware, Naval P. (The University of Wisconsin-Madison Medical School, WI, Madison, USA)</creator><creator>Williams, Leah M. (The University of Wisconsin-Madison Medical School, WI, Madison, USA)</creator><creator>Bowler, Michael J. (The University of Wisconsin-Madison Medical School, WI, Madison, USA)</creator><creator>Tibbetts, Randal S. (The University of Wisconsin-Madison Medical School, WI, Madison, USA), E-mail: rstibbetts@wisc.edu</creator><scope>FBQ</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>5PM</scope></search><sort><creationdate>20090331</creationdate><title>Non-specific in vivo inhibition of CK1 by the pyridinyl imidazole p38 inhibitors SB 203580 and SB 202190</title><author>Shanware, Naval P. (The University of Wisconsin-Madison Medical School, WI, Madison, USA) ; Williams, Leah M. (The University of Wisconsin-Madison Medical School, WI, Madison, USA) ; Bowler, Michael J. (The University of Wisconsin-Madison Medical School, WI, Madison, USA) ; Tibbetts, Randal S. (The University of Wisconsin-Madison Medical School, WI, Madison, USA), E-mail: rstibbetts@wisc.edu</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c545t-662e1cf0abe5aceeee60e1c5800a8d47d83828cf8342cb6a058d678dc70e7a883</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2009</creationdate><topic>Casein kinase</topic><topic>Casein Kinase I - antagonists &amp; inhibitors</topic><topic>Cell Line</topic><topic>CICLOHEXIMIDA</topic><topic>CK1</topic><topic>CK2</topic><topic>CREB</topic><topic>Cyclic AMP Response Element-Binding Protein - metabolism</topic><topic>CYCLOHEXIMIDE</topic><topic>Humans</topic><topic>Imidazoles - pharmacology</topic><topic>Non-specific</topic><topic>p38</topic><topic>p38 Mitogen-Activated Protein Kinases - antagonists &amp; inhibitors</topic><topic>Phosphorylation - drug effects</topic><topic>Phosphoserine - metabolism</topic><topic>Protein Biosynthesis - drug effects</topic><topic>Protein Kinase Inhibitors - pharmacology</topic><topic>Pyridines - pharmacology</topic><topic>SB202190</topic><topic>SB203580</topic><topic>Stress, Physiological - drug effects</topic><topic>Stress-activated protein kinase</topic><topic>Substrate Specificity - drug effects</topic><topic>Suppression, Genetic - drug effects</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Shanware, Naval P. (The University of Wisconsin-Madison Medical School, WI, Madison, USA)</creatorcontrib><creatorcontrib>Williams, Leah M. (The University of Wisconsin-Madison Medical School, WI, Madison, USA)</creatorcontrib><creatorcontrib>Bowler, Michael J. (The University of Wisconsin-Madison Medical School, WI, Madison, USA)</creatorcontrib><creatorcontrib>Tibbetts, Randal S. (The University of Wisconsin-Madison Medical School, WI, Madison, USA), E-mail: rstibbetts@wisc.edu</creatorcontrib><collection>AGRIS</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>BMB reports</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Shanware, Naval P. (The University of Wisconsin-Madison Medical School, WI, Madison, USA)</au><au>Williams, Leah M. (The University of Wisconsin-Madison Medical School, WI, Madison, USA)</au><au>Bowler, Michael J. (The University of Wisconsin-Madison Medical School, WI, Madison, USA)</au><au>Tibbetts, Randal S. (The University of Wisconsin-Madison Medical School, WI, Madison, USA), E-mail: rstibbetts@wisc.edu</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Non-specific in vivo inhibition of CK1 by the pyridinyl imidazole p38 inhibitors SB 203580 and SB 202190</atitle><jtitle>BMB reports</jtitle><addtitle>BMB Rep</addtitle><date>2009-03-31</date><risdate>2009</risdate><volume>42</volume><issue>3</issue><spage>142</spage><epage>147</epage><pages>142-147</pages><issn>1976-6696</issn><eissn>1976-670X</eissn><abstract>Small-molecule inhibitors of protein kinases have contributed immensely to our understanding of biological signaling pathways and have been exploited therapeutically for the treatment of cancers and other disease states. The pyridinyl imidazole compounds SB 203580 and SB 202190 were identified as ATP competitive antagonists of the p38 stress-activated protein kinases and have been widely used to elucidate p38-dependent cellular processes. Here, we identify S8 203580 and SB 202190 as potent inhibitors of stress-induced CREB phosphorylation on Serine 111 (Ser-111) in intact cells. Unexpectedly, we found that the inhibitory activity of SB 203580 and SB 202190 on CREB phosphorylation was independent of p38, but instead correlated with inhibition of casein kinase 1 (CK1) in vitro. The inhibition of CK1-mediated CREB phosphorylation by concentrations of pyridinyl imidazoles commonly employed to suppress p38, suggests that in some cases conclusions of p38-dependence derived solely from the use of these inhibitors may be invalid.</abstract><cop>Korea (South)</cop><pmid>19336000</pmid><doi>10.5483/bmbrep.2009.42.3.142</doi><tpages>6</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1976-6696
ispartof BMB reports, 2009-03, Vol.42 (3), p.142-147
issn 1976-6696
1976-670X
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4412876
source Free Full-Text Journals in Chemistry
subjects Casein kinase
Casein Kinase I - antagonists & inhibitors
Cell Line
CICLOHEXIMIDA
CK1
CK2
CREB
Cyclic AMP Response Element-Binding Protein - metabolism
CYCLOHEXIMIDE
Humans
Imidazoles - pharmacology
Non-specific
p38
p38 Mitogen-Activated Protein Kinases - antagonists & inhibitors
Phosphorylation - drug effects
Phosphoserine - metabolism
Protein Biosynthesis - drug effects
Protein Kinase Inhibitors - pharmacology
Pyridines - pharmacology
SB202190
SB203580
Stress, Physiological - drug effects
Stress-activated protein kinase
Substrate Specificity - drug effects
Suppression, Genetic - drug effects
title Non-specific in vivo inhibition of CK1 by the pyridinyl imidazole p38 inhibitors SB 203580 and SB 202190
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-10T17%3A00%3A17IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmed_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Non-specific%20in%20vivo%20inhibition%20of%20CK1%20by%20the%20pyridinyl%20imidazole%20p38%20inhibitors%20SB%20203580%20and%20SB%20202190&rft.jtitle=BMB%20reports&rft.au=Shanware,%20Naval%20P.%20(The%20University%20of%20Wisconsin-Madison%20Medical%20School,%20WI,%20Madison,%20USA)&rft.date=2009-03-31&rft.volume=42&rft.issue=3&rft.spage=142&rft.epage=147&rft.pages=142-147&rft.issn=1976-6696&rft.eissn=1976-670X&rft_id=info:doi/10.5483/bmbrep.2009.42.3.142&rft_dat=%3Cpubmed_cross%3E19336000%3C/pubmed_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c545t-662e1cf0abe5aceeee60e1c5800a8d47d83828cf8342cb6a058d678dc70e7a883%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_id=info:pmid/19336000&rfr_iscdi=true